These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33789873)

  • 21. Description of a novel splice site variant in UBA1 gene causing VEXAS syndrome.
    Ospina Cardona D; Rodriguez-Pinto I; Iosim S; Bonet N; Mensa-Vilaro A; Wong MK; Ho G; Tormo M; Yagüe J; Shon W; Wallace DJ; Casals F; Beck DB; Abuav R; Arostegui JI
    Rheumatology (Oxford); 2024 Oct; 63(10):2897-2902. PubMed ID: 38552317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Restatement. Relapsing polychondritis].
    Mertz P; Arnaud L
    Rev Prat; 2023 May; 73(5):549-556. PubMed ID: 37309797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients.
    Khitri MY; Guedon AF; Georgin-Lavialle S; Terrier B; Saadoun D; Seguier J; le Besnerais M; De Moreuil C; Denis G; Gerfaud-Valentin M; Allain JS; Maria A; Bouillet L; Grobost V; Galland J; Kosmider O; Dumont A; Devaux M; Subran B; Schmidt J; Marianetti-Guingel P; Audia S; Palat S; Roux-Sauvat M; Jachiet V; Hirsch P; Fain O; Mekinian A;
    RMD Open; 2022 Jul; 8(2):. PubMed ID: 35868738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Heterogeneity of the VEXAS Syndrome: A Case Series.
    Koster MJ; Kourelis T; Reichard KK; Kermani TA; Beck DB; Cardona DO; Samec MJ; Mangaonkar AA; Begna KH; Hook CC; Oliveira JL; Nasr SH; Tiong BK; Patnaik MM; Burke MM; Michet CJ; Warrington KJ
    Mayo Clin Proc; 2021 Oct; 96(10):2653-2659. PubMed ID: 34489099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
    Kunishita Y; Kirino Y; Tsuchida N; Maeda A; Sato Y; Takase-Minegishi K; Yoshimi R; Nakajima H
    Front Immunol; 2022; 13():901063. PubMed ID: 35769485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEXAS syndrome in dermatology.
    Afsahi V; Christensen RE; Alam M
    Arch Dermatol Res; 2023 Mar; 315(2):161-164. PubMed ID: 35201420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Challenges of Emerging Acquired Autoinflammatory Diseases, Including VEXAS Syndrome.
    Kirino Y
    Intern Med; 2024 Feb; ():. PubMed ID: 38296470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin Manifestations of VEXAS Syndrome and Associated Genotypes.
    Tan IJ; Ferrada MA; Ahmad S; Fike A; Quinn KA; Groarke EM; Beck DB; Allbritton J; Castelo-Soccio L; Young NS; Patel BA; Grayson PC; Cowen EW
    JAMA Dermatol; 2024 Aug; 160(8):822-829. PubMed ID: 38865133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about
    Mascaro JM; Rodriguez-Pinto I; Poza G; Mensa-Vilaro A; Fernandez-Martin J; Caminal-Montero L; Espinosa G; Hernández-Rodríguez J; Diaz M; Rita-Marques J; Sanmarti R; Castañeda S; Colunga D; Coto-Hernández R; Fanlo P; Elejalde JI; Bujan S; Figueras I; Marco FM; Andrés M; Suárez S; Gonzalez-Garcia A; Fustà-Novell X; Garcia-Belando C; Granados A; Fernandez-Figueras MT; Quilis N; Orriols-Caba M; Gómez de la Torre R; Cid MC; Espígol-Frigolé G; Alvarez-Abella A; Labrador E; Rozman M; Lopez-Guerra M; Castillo P; Alamo-Moreno JR; Gonzalez-Roca E; Plaza S; Fabregat V; Lara R; Vicente-Rabaneda EF; Tejedor-Vaquero S; Magri G; Bonet N; Solis-Moruno M; Cerutti A; Fornas O; Casals F; Yagüe J; Aróstegui JI
    Ann Rheum Dis; 2023 Dec; 82(12):1594-1605. PubMed ID: 37666646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
    Kirino Y; Takase-Minegishi K; Tsuchida N; Hirahara L; Kunishita Y; Yoshimi R; Nakajima H
    Ann Rheum Dis; 2021 Nov; 80(11):1501-1502. PubMed ID: 34260381
    [No Abstract]   [Full Text] [Related]  

  • 34. Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort.
    Gurnari C; Pascale MR; Vitale A; Diral E; Tomelleri A; Galossi E; Falconi G; Bruno A; Crisafulli F; Frassi M; Cattaneo C; Bertoli D; Bernardi M; Condorelli A; Morsia E; Poloni A; Crisà E; Caravelli D; Triggianese P; Brussino L; Battipaglia G; Bindoli S; Sfriso P; Caroni F; Dragani M; Mallegni F; Pilo F; Firinu D; Curti A; Papayannidis C; Olivieri A; Kordasti S; Albano F; Pane F; Musto P; Bocchia M; Lugli E; Breccia M; Frigeni M; Dagna L; Greco R; Franceschini F; Campochiaro C; Cantarini L; Voso MT
    Am J Hematol; 2024 Feb; 99(2):254-262. PubMed ID: 38108611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VEXAS syndrome.
    Grayson PC; Patel BA; Young NS
    Blood; 2021 Jul; 137(26):3591-3594. PubMed ID: 33971000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on VEXAS syndrome.
    Al-Hakim A; Savic S
    Expert Rev Clin Immunol; 2023 Feb; 19(2):203-215. PubMed ID: 36537591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. VEXAS syndrome: relapsing polychondritis and myelodysplastic syndrome with associated immunoglobulin A vasculitis.
    Pàmies A; Ferràs P; Bellaubí-Pallarés N; Giménez T; Raventós A; Colobran R
    Rheumatology (Oxford); 2022 Mar; 61(3):e69-e71. PubMed ID: 34668539
    [No Abstract]   [Full Text] [Related]  

  • 38. A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome.
    Pozdniakova H; Vedire A; Kadakia A; Imburgio S; Bajwa R; Gupta V; Bhatt R; Hossain MA
    J Med Cases; 2023 Oct; 14(9-10):327-331. PubMed ID: 37868330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
    Muratore F; Marvisi C; Castrignanò P; Nicoli D; Farnetti E; Bonanno O; Longo R; Zaldini P; Galli E; Balanda N; Beck DB; Grayson PC; Pipitone N; Boiardi L; Salvarani C
    Arthritis Rheumatol; 2022 Apr; 74(4):665-670. PubMed ID: 34611997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comment on: Efficient detection of somatic UBA1 variants and clinical scoring system predicting patients with variants in VEXAS syndrome: reply.
    Tsuchida N; Uchiyama Y; Maeda A; Horita N; Kirino Y; Matsumoto N
    Rheumatology (Oxford); 2024 Aug; 63(8):e229-e230. PubMed ID: 38059601
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.